{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:48Z","timestamp":1786119288691,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/iae.0b013e3181bced93","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T03:17:41Z","timestamp":1262661461000},"page":"160-166","source":"Crossref","is-referenced-by-count":11,"title":["A RANDOMIZED, DOUBLE-MASKED CONTROLLED CLINICAL TRIAL OF SANDOSTATIN LONG-ACTING RELEASE DEPOT IN PATIENTS WITH POSTSURGICAL CYSTOID MACULAR EDEMA"],"prefix":"10.1097","volume":"30","author":[{"given":"SYED MAHMOOD ALI","family":"SHAH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QUAN DONG","family":"NGUYEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAFSA SYYIDA","family":"MIR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANTONIO","family":"POLITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GULNAR","family":"HAFIZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SINAN","family":"TATLIPINAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DIANA V.","family":"DO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUSAN","family":"VITALE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JULIA A.","family":"HALLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210130","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1167\/iovs.03-0955","article-title":"Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412.","volume":"45","author":"Campochiaro","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R2-22-20210130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1167\/iovs.03-0557","article-title":"Supplemental oxygen improves diabetic macular edema: a pilot study.","volume":"45","author":"Nguyen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-22-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.","volume":"98","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"R4-22-20210130","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report.","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"R5-22-20210130","first-page":"O515","article-title":"Cystoid macular edema in retinitis pigmentosa.","volume":"83","author":"Fetkenhour","year":"1977","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"R6-22-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1023\/A:1002525619764","article-title":"Medical treatment of macular edema in patients with uveitis.","volume":"97","author":"Rojas","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"R7-22-20210130","first-page":"665","article-title":"Follow-up study of cystoid macular edema following cataract extraction.","volume":"73","author":"Gass","year":"1969","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"R8-22-20210130","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archopht.1988.01060140040018","article-title":"Cystoid macular edema following cataract surgery.","volume":"106","author":"Jampol","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R9-22-20210130","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archopht.1985.01050080046017","article-title":"Aphakic cystoid macular edema. A hypothesis.","volume":"103","author":"Jampol","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R10-22-20210130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-1549(02)00041-X","article-title":"Update on pseudophakic cystoid macular edema treatment options.","volume":"15","author":"Levin","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"R11-22-20210130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004397-198702730-00009","article-title":"Medical and surgical treatment of aphakic cystoid macular edema.","volume":"27","author":"Milch","year":"1987","journal-title":"Int Ophthalmol Clin"},{"key":"R12-22-20210130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0161-6420(82)34709-0","article-title":"Surgical therapy for chronic aphakic cystoid macular edema.","volume":"89","author":"Fung","year":"1982","journal-title":"Ophthalmology"},{"key":"R13-22-20210130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0161-6420(98)93018-4","article-title":"Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis.","volume":"105","author":"Rossetti","year":"1998","journal-title":"Ophthalmology"},{"key":"R14-22-20210130","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0886-3350(99)00159-5","article-title":"Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone.","volume":"25","author":"Abe","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"R15-22-20210130","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.2337\/diacare.25.12.2282","article-title":"Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.","volume":"25","author":"Simo","year":"2002","journal-title":"Diabetes Care"},{"key":"R16-22-20210130","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bjo.84.5.542","article-title":"Macular oedema: the role of soluble mediators.","volume":"84","author":"Kent","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R17-22-20210130","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF00158291","article-title":"Immunohistochemical localization of blood\u2013retinal barrier breakdown sites associated with post-surgical macular oedema.","volume":"26","author":"Vinores","year":"1994","journal-title":"Histochem J"},{"key":"R18-22-20210130","first-page":"1626","article-title":"Age and topographic variation of insulin-like growth factor-binding protein 2 in the human RPE.","volume":"42","author":"Miyamura","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-22-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0169-328X(92)90082-M","article-title":"Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells.","volume":"12","author":"Martin","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"key":"R20-22-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.exer.2004.06.007","article-title":"Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells.","volume":"79","author":"Sall","year":"2004","journal-title":"Exp Eye Res"},{"key":"R21-22-20210130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bjo.81.3.228","article-title":"Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.","volume":"81","author":"Boulton","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R22-22-20210130","first-page":"2S13","article-title":"Regulation of cell proliferation by somatostatin [in French].","volume":"63","author":"Buscail","year":"2002","journal-title":"Ann Endocrinol (Paris)"},{"key":"R23-22-20210130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00417-002-0441-7","article-title":"Octreotide inhibits growth factor-induced bovine choriocapillary endothelial cells in vitro.","volume":"240","author":"Spraul","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R24-22-20210130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ijc.1223","article-title":"Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells.","volume":"92","author":"Mentlein","year":"2001","journal-title":"Int J Cancer"},{"key":"R25-22-20210130","first-page":"2329","article-title":"Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration.","volume":"41","author":"Lambooij","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-22-20210130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0167-0115(93)90356-D","article-title":"Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization.","volume":"48","author":"Grant","year":"1993","journal-title":"Regul Pept"},{"key":"R27-22-20210130","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S1096-6374(01)80009-5","article-title":"Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy.","volume":"11","author":"Wilson","year":"2001","journal-title":"Growth Horm IGF Res"},{"key":"R28-22-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0143-4179(90)90135-L","article-title":"Cellular localization of somatostatin mRNA in rat retina.","volume":"17","author":"Yamaguchi","year":"1990","journal-title":"Neuropeptides"},{"key":"R29-22-20210130","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1523\/JNEUROSCI.04-12-03069.1984","article-title":"Localization, chromatographic characterization, and development of somatostatin-like immunoreactivity in the guinea pig retina.","volume":"4","author":"Spira","year":"1984","journal-title":"J Neurosci"},{"key":"R30-22-20210130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0006-8993(80)90708-8","article-title":"Immunoreactive and biologically active somatostatin-like material in the human retina.","volume":"199","author":"Rorstad","year":"1980","journal-title":"Brain Res"},{"key":"R31-22-20210130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(82)90907-6","article-title":"Somatostatin-like immunoreactive material in the rabbit retina.","volume":"244","author":"Sagar","year":"1982","journal-title":"Brain Res"},{"key":"R32-22-20210130","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1073\/pnas.76.6.3019","article-title":"Immunoreactive and biologically active somatostatin-like material in rat retina.","volume":"76","author":"Rorstad","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33-22-20210130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(88)90284-9","article-title":"Somatostatin-like immunoreactive material in associational ganglion cells of human retina.","volume":"27","author":"Sagar","year":"1988","journal-title":"Neuroscience"},{"key":"R34-22-20210130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1056\/NEJM199802263380917","article-title":"Treatment of cystoid macular edema with octreotide.","volume":"338","author":"Kuijpers","year":"1998","journal-title":"N Engl J Med"},{"key":"R35-22-20210130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/112067210201200601","article-title":"The protective effects of melatonin, vitamin E and octreotide on retinal edema during ischemia\u2013reperfusion in the guinea pig retina.","volume":"12","author":"Yilmaz","year":"2002","journal-title":"Eur J Ophthalmol"},{"key":"R36-22-20210130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-2001-15282","article-title":"Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy.","volume":"33","author":"Boehm","year":"2001","journal-title":"Horm Metab Res"},{"key":"R37-22-20210130","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1210\/jc.2001-012012","article-title":"Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.","volume":"87","author":"Bevan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-22-20210130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1445-2197.2002.02507.x","article-title":"Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours.","volume":"72","author":"Rohaizak","year":"2002","journal-title":"ANZ J Surg"},{"key":"R39-22-20210130","first-page":"262","article-title":"Chronic cystoid macular edema and predictors of visual acuity.","volume":"24","author":"Spaide","year":"1993","journal-title":"Ophthalmic Surg"},{"key":"R40-22-20210130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajo.2004.04.021","article-title":"Optical coherence tomography and confocal scanning laser tomography for assessment of macular edema.","volume":"138","author":"Degenring","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R41-22-20210130","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0161-6420(82)34698-9","article-title":"Pathology of cystoid macular edema.","volume":"89","author":"Tso","year":"1982","journal-title":"Ophthalmology"},{"key":"R42-22-20210130","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2337\/diab.44.10.1209","article-title":"Treatment with insulin-like growth factor I alters capillary permeability in skin and retina.","volume":"44","author":"Hussain","year":"1995","journal-title":"Diabetes"},{"key":"R43-22-20210130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jcp.10238","article-title":"Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood\u2013retinal barrier.","volume":"195","author":"Saishin","year":"2003","journal-title":"J Cell Physiol"},{"key":"R44-22-20210130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF00400229","article-title":"Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor.","volume":"36","author":"Grant","year":"1993","journal-title":"Diabetologia"},{"key":"R45-22-20210130","first-page":"99","article-title":"Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.","volume":"12","author":"Vinores","year":"1997","journal-title":"Histol Histopathol"},{"key":"R46-22-20210130","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.","volume":"5","author":"Smith","year":"1999","journal-title":"Nat Med"},{"key":"R47-22-20210130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diabres.2003.10.003","article-title":"Sandostatin LAR for cystoid diabetic macular edema: a 1-year experience","volume":"64","author":"Hernaez-Ortega","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"R48-22-20210130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diacare.23.4.504","article-title":"The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.","volume":"23","author":"Grant","year":"2000","journal-title":"Diabetes Care"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-201001000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:35Z","timestamp":1786039895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201001000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181bced93","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}